These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11265778)

  • 21. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ongoing evolution of dendritic cell therapy.
    Sokoloff MH; Vogelzang N
    Cancer; 1999 Dec; 86(12):2593-6. PubMed ID: 10594853
    [No Abstract]   [Full Text] [Related]  

  • 23. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
    Schultze JL; Grabbe S; von Bergwelt-Baildon MS
    Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 25. Third international Dresden symposium on immunotherapy of cancer.
    Schmitz M; Bornhauser M; Ockert D; Rieber EP
    Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12.
    Homma S; Kikuchi T; Ishiji N; Ochiai K; Takeyama H; Saotome H; Sagawa Y; Hara E; Kufe D; Ryan JL; Ohno T; Toda G
    Eur J Clin Invest; 2005 Apr; 35(4):279-86. PubMed ID: 15816998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor immunotherapy: inching toward the finish line.
    Curiel TJ; Curiel DT
    J Clin Invest; 2002 Feb; 109(3):311-2. PubMed ID: 11827989
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer therapy-induced immune modulation.
    Karl JC; Mackall CL
    Cancer Chemother Biol Response Modif; 2005; 22():325-41. PubMed ID: 16110619
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cancer immunotherapy using dendritic cells: current status and perspective].
    Okano S; Yonemitsu Y; Sueishi K
    Fukuoka Igaku Zasshi; 2007 Jul; 98(7):277-86. PubMed ID: 17710892
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
    Breckpot K; Heirman C; Neyns B; Thielemans K
    J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J; Pajtasz-Piasecka E
    Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumoral immunotherapy and gastrointestinal tract: specific immunotherapy using dendritic cells and potential interest of heat shock proteins].
    Papillon E; Fournet J; Zarski JP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):380-90. PubMed ID: 11449127
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-based tumor immunotherapy.
    Kadowaki N; Kitawaki T
    Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
    [No Abstract]   [Full Text] [Related]  

  • 36. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dendritic cells and cancer therapy].
    Baggers J
    Ugeskr Laeger; 2000 Oct; 162(44):5940-1. PubMed ID: 11094562
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
    Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
    J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells for specific cancer immunotherapy.
    Meidenbauer N; Andreesen R; Mackensen A
    Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
    Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
    J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.